KNSA Kiniksa Pharmaceuticals International, plc
KNSA Kiniksa Pharmaceuticals International, plc
Healthcare · Drug Manufacturers - Specialty & Generic
Market read
Scan convergence 1 scan as of 2026-08-17 1 bull converging
POC $41.60 · VWAP $48.97 · +61.7% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
KNSA Price Structure
Loading timeframes…
Peers
Every watchlist KNSA belongs to, members best 30-day change first — KNSA highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported EPS $0.30 versus analyst consensus of $0.28 (+5.3%).
full note →Against street estimates
How KNSA's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
KNSA research tape
11 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.